"10.1371_journal.pone.0045571","none","2012-09-19T00:00:00Z","Xiang Ling; Shousong Cao; Qiuying Cheng; James T Keefe; Youcef M Rustum; Fengzhi Li","Departments of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, United States of America; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, United States of America; NCI-supported Experimental Therapeutics Program, Roswell Park Cancer Institute, Buffalo, New York, United States of America","Conceived and designed the experiments: XL SC YMR FL. Performed the experiments: XL SC QC JTK FL. Analyzed the data: XL SC. Contributed reagents/materials/analysis tools: SC YMR FL. Wrote the paper: FL. Read and revised the manuscript: XL SC QC JTK YMR FL.","FL118 will be further developed in Canget BioTekpharma (www.canget-biotek.com), a Roswell Park Cancer Institute (RPCI) spinoff company founded by the PI. Otherwise, there is no conflict of interest.","2012","09","Xiang Ling","XL",6,TRUE,4,5,2,1,TRUE,TRUE,FALSE,0,NA,FALSE
